Current management of endometrial hyperplasia and endometrial intraepithelial neoplasia (EIN)

European Journal of Gynaecological Oncology

Volumn 30, Issue 4, 2009, Pages 396-401

  Gultekin M ^a,c   Diribas K ^a   Dursun, P ^b   Ayhan, A ^b  

^a Cankiri Government Hospital   (Turkey)

^b BASKENT UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Endometrial hyperplasia; Endometrial intraepithelial neoplasia (EIN)

Indexed keywords

AROMATASE INHIBITOR; DANAZOL; ESTROGEN; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; MIFEPRISTONE; NORETHISTERONE ACETATE; ORAL CONTRACEPTIVE AGENT; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGESTERONE; TRIPTORELIN;

ARTICLE; CANCER GROWTH; CANCER RISK; DISEASE CLASSIFICATION; DRUG MEGADOSE; DRUG SAFETY; ENDOMETRIAL INTRAEPITHELIAL NEOPLASIA; ENDOMETRIUM BIOPSY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; ENDOMETRIUM TUMOR; FEMALE FERTILITY; GENITAL TRACT CANCER; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; LOW DRUG DOSE; OVULATION INDUCTION; PROGNOSIS; UNSPECIFIED SIDE EFFECT;

ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; PROGNOSIS; RISK FACTORS;

EID: 68849085164     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Montgomery B.E., Daum G.S., Dunton C.J.: "Endometrial hyperplasia: a review". Obstet. Gynecol. Surv., 2004, 59, 368.
2. Soslow R.A.: "Problems with the current diagnostic approach to complex atypical endometrial hyperplasia". Cancer, 2006, 106, 729.
3. Gücer F., Reich O., Tamussino K., Bader A.A., Pieber D., Scholl W., Haas J., Petru E.: "Concomitant endometrial hyperplasia in patients with endometrial carcinoma". Gynecol. Oncol., 1998, 69, 64. (Pubitemid 28201673)
4. Pickar J.H., Archer D.F.: "Is bleeding a predictor of endometrial hyperplasia in postmenopausal women receiving hormone replacement therapy?". Menopause Study Group (United States, Italy, Netherlands, Switzerland, Belgium, Germany, and Finland. Am. J. Obstet. Gynecol., 1997, 177, 1178.
5. Karamursel B.S., Guven S., Tulunay G., Kucukali T., Ayhan A.: "Which surgical procedure for patients with atypical endometrial hyperplasia?". Int. J. Gynecol. Cancer, 2005, 15, 127. (Pubitemid 40194343)
6. Kurman R.J., Kaminski P.F., Norris H.J.: "The behavior of endometrial hyperplasia. A long-term study of 'untreated' hyperplasia in 170 patients". Cancer, 1985, 56, 403.
7. Janicek M.F., Rosenshein N.B.: "Invasive endometrial cancer in uteri resected for atypical endometrial hyperplasia". Gynecol. Oncol., 1994, 52, 373.
8. Dunton C.J., Baak J.P., Palazzo J.P., van Diest P.J., McHugh M., Widra E.A.: "Use of computerized morphometric analyses of endometrial hyperplasias in the prediction of coexistent cancer". Am. J. Obstet. Gynecol., 1996, 174, 1518. (Pubitemid 26165271)
9. Clark T.J., Neelakantan D., Gupta J.K.: "The management of endometrial hyperplasia: an evaluation of current practice". Eur. J. Obstet. Gynecol. Reprod. Biol., 2006, 125, 259.
10. nd et al.: "Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study". Cancer, 2006, 106, 812. (Pubitemid 43238448)
11. Ferenczy A., Gelfand M.M., Tzipris F.: "The cytodynamics of endometrial hyperplasia and carcinoma. A review". Ann. Pathol., 1983, 3, 189. (Pubitemid 14229304)
12. Norimatsu Y., Shimizu K., Kobayashi T.K., Moriya T., Tsukayama C., Miyake Y., Ohno E.: "Cellular features of endometrial hyperplasia and well differentiated adenocarcinoma using the endocyte sampler: Diagnostic criteria based on the cytoarchitecture of tissue fragments". Cancer, 2006, 108, 77.
13. Emoto M., Tamura R., Shirota K., Hachisuga T., Kawarabayashi T.: "Clinical usefulness of color Doppler ultrasound in patients with endometrial hyperplasia and carcinoma". Cancer, 2002, 94, 700. (Pubitemid 34132298)
14. Arslan M., Erdem A., Erdem M., Yazici G., Himmetoglu O., Gursoy R.: "Transvaginal color Doppler ultrasonography for prediction of pre-cancerous endometrial lesions". Int. J. Gynaecol. Obstet., 2003, 80, 299. (Pubitemid 36298760)
15. Smith-Bindman R., Kerlikowske K., Feldstein V.A., Subak L., Scheidler J., Segal M., Brand R., Grady D.: "Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities". JAMA, 1998, 280, 1510. (Pubitemid 28507404)
16. Fleischer A.C., Wheeler J.E., Lindsay I., Hendrix S.L., Grabill S., Kravitz B., MacDonald B.: "An assessment of the value of ultrasonographic screening for endometrial disease in postmenopausal women without symptoms". Am. J. Obstet. Gynecol., 2001, 184, 70. (Pubitemid 32141645)
17. Wilailak S., Jirapinyo M., Theppisai U.: "Transvaginal Doppler sonography: is there a role for this modality in the evaluation of women with postmenopausal bleeding?". Maturitas, 2005, 50, 111. (Pubitemid 40094758)
18. Mercé L.T., Alcázar J.L., Engels V., Troyano J., Bau S., Bajo J.M.: "Endometrial volume and vascularity measurements by transvaginal three-dimensionalultrasonography and power Doppler angiography in stimulated and tumoral endometria: intraobserver reproducibility". Gynecol. Oncol., 2006, 100, 544. (Pubitemid 43246870)
19. Feldman S., Berkowitz R.S., Tosteson A.N.: "Cost-effectiveness of strategies to evaluate postmenopausal bleeding". Obstet. Gynecol., 1993, 81, 968. (Pubitemid 23168743)
20. Dijkhuizen F.P., Mol B.W., Brölmann H.A., Heintz A.P.: "The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis". Cancer, 2000, 89, 1765.
21. Xie X., Lu W.G., Ye D..F, Chen H.Z., Fu Y.F.: "The value of curettage in diagnosis of endometrial hyperplasia". Gynecol. Oncol., 2002, 84, 135. (Pubitemid 34056479)
22. Elsandabesee D., Greenwood P.: "The performance of Pipelle endometrial sampling in a dedicated postmenopausal bleeding clinic". J. Obstet. Gynaecol., 2005, 25, 32. (Pubitemid 41685672)
23. Arslan S., Aytan H., Gunyeli I., Koc O., Tuncay G., Tapisiz O.L.: "Office hysteroscopic evaluation of endometrium: can we hit the target?". Arch. Gynecol. Obstet., 2005, 271, 200. (Pubitemid 40562094)
24. Arslan S., Gökmen O., Tuncay G.: "The office hysteroscopic evaluation of postmenopausal patients". Arch. Gynecol. Obstet., 2004, 270, 31. (Pubitemid 38915729)
25. Garuti G., Mirra M., Luerti M.: "Hysteroscopic view in atypical endometrial hyperplasias: A correlation with pathologic findings on hysterectomy specimens". J. Minim. Invasive Gynecol., 2006, 13, 325. (Pubitemid 43975037)
26. Lasmar R.B., Dias R., Barrozo P.R., Oliveira M.A., Coutinho Eda S., da Rosa D.B.: "Prevalence of hysteroscopic findings and histologic diagnoses in patients with abnormal uterine bleeding". Fertil Steril., 2008, 89, 1803. (Pubitemid 351749625)
27. Lasmar R.B., Barrozo P.R., de Oliveira M.A., Coutinho E.S., Dias R.: "Validation of hysteroscopic view in cases of endometrial hyperplasia and cancer in patients with abnormal uterine bleeding". J. Minim. Invasive Gynecol., 2006, 13, 409.
28. Clark T.J., Voit D., Gupta J.K., Hyde C., Song F., Khan K.S.: "Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review". JAMA, 2002, 288, 1610.
29. Scully R.E., Bonfiglio T.A., Kurman R.J., Silverberg S.G., Wilkinson E.J.: "Uterine corpus". Histological Typing of Female Genital Tract Tumors. New York, Springer-Verlag, 1994, 13.
30. Kendall B.S., Ronnett B.M., Isacson C., Cho K.R., Hedrick L., Diener-West M., Kurman R.J.: "Reproducibility of diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma". Am. J. Surg. Pathol., 1998, 22, 1012. (Pubitemid 28364502)
31. Bergeron C., Nogales F., Masseroli M., Abeler V., Duvillard P., Müller-Holzner E. et al.: "A multicentric European study testing the reproducibility of the WHO Classification of endometrial hyperplasia with a proposal of a simplified working classification for biopsy and curettage specimens". Am. J. Surg. Pathol., 1999, 23, 1102. (Pubitemid 29409773)
32. Zaino R.J., Kauderer J., Trimble C.L., Silverberg S.G., Curtin J.P., Lim P.C., Gallup D.G.: "Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study". Cancer, 2006, 106, 804. (Pubitemid 43238447)
33. Mutter G.L.: "Histopathology of genetically defined endometrial precancers". Int. J. Gynecol. Pathol., 2000, 19, 301.
34. Mutter C.L., Baak J.P., Crum C.P., Richart R.M., Ferenczy A., Faquin W.C.: "Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry". J. Pathol., 2000, 190, 462. (Pubitemid 30163587)
35. Mutter G.L.: "Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group". Gynecol. Oncol., 2000, 76, 287.
36. Mutter G.L., Zaino R.J., Baak J.P., Bentley R.C., Robboy S.J.: "Benign endometrial hyperplasia sequence and endometrial intraepithelial neoplasia". Int. J. Gynecol. Pathol., 2007, 26, 103.
37. Mohan H., Baak J.P.: "Morphometrical analysis in endometrial hyperplasia: predictive of progression to cancer". Indian J. Pathol. Microbiol., 2006, 49, 21.
38. Orbo A., Baak J.P., Kleivan I., Lysne S., Prytz P.S., Broeckaert M.A. et al.: "Computerised morphometrical analysis in endometrial hyperplasia for the prediction of cancer development. A long-term retrospective study from northern Norway". J. Clin. Pathol., 2000, 53, 697. (Pubitemid 30692409)
39. Baak J.P., Mutter G.L.: "EIN and WHO94". J. Clin. Pathol., 2005, 58, 1.
40. Baak J.P., Ørbo A., van Diest P.J., Jiwa M., de Bruin P., Broeckaert M. et al.: "Prospective multicenter evaluation of the morphometric D-score for prediction of the outcome of endometrial hyperplasias". Am. J. Surg. Pathol., 2001, 25, 930.
41. Baak J.P.: "The role of computerized morphometric and cytometric feature analysis in endometrial hyperplasia and cancer prognosis". J. Cell. Biochem. Suppl., 1995, 23, 137.
42. Mutter G.L.: "Diagnosis of premalignant endometrial disease". J. Clin. Pathol., 2002, 55, 326.
43. Hecht J.L., Ince T.A., Baak J.P., Baker H.E., Ogden M.W., Mutter G.L.: "Prediction of endometrial carcinoma by subjective endometrial intraepithelial neoplasia diagnosis". Mod. Pathol., 2005, 18, 324.
44. Marsden D.E., Hacker N.F.: "Optimal management of endometrial hyperplasia". Best. Pract. Res. Clin. Obstet. Gynaecol., 2001, 15, 393.
45. Lethaby A., Irvine G., Cameron I.: "Cyclical progestogens for heavy menstrual bleeding". Cochrane Database Syst. Rev., 2000.
46. Lethaby A., Shepperd S., Cooke I., Farquhar C.: "Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding". Cochrane Database Syst. Rev., 2000.
47. Archer D.F.: "The effect of the duration of progestin use on the occurrence of endometrial cancer in postmenopausal women". Menopause, 2001, 8, 245.
48. Ferenczy A., Gelfand M.: "The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia". Am. J. Obstet. Gynecol., 1989, 160, 126. (Pubitemid 19055273)
49. Randall T.C., Kurman R.J.: "Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40". Obstet. Gynecol., 1997, 90, 434.
50. Gal D.: "Hormonal therapy for lesions of the endometrium". Semin. Oncol., 1986, 13 (suppl. 4), 33.
51. Lindahl B., Alm P., Fernö M., Killander D., Långström E., Norgren A., Tropé C.: "Prognostic value of steroid receptor concentration and flow cytometrical DNA measurements in Stage I-II endometrial carcinoma". Acta Oncol., 1989, 28, 595. (Pubitemid 19238888)
52. Wildemeersch D., Dhont M.: "Treatment of nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system". Am. J. Obstet. Gynecol., 2003, 188, 1297. (Pubitemid 36589125)
53. Pérez-Medina T., Bajo J., Folgueira G., Haya J., Ortega P.: "Atypical endometrial hyperplasia treatment with progestogens and gonadotropin-releasing hormone analogues: long-term follow-up". Gynecol. Oncol., 1999, 73, 299. (Pubitemid 29215747)
54. Sedati A., Mariani L., Giovinazzi R., Yacoub M., Atlante G.: "The effectiveness of danazol therapy in postmenopausal women affected by endometrial hyperplasia". Clin. Exp. Obstet. Gynecol., 1992, 19, 161.
55. Grimbizis G., Tsalikis T., Tzioufa V., Kasapis M., Mantalenakis S.: "Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptorelin: a prospective study". Hum. Reprod., 1999, 14, 479. (Pubitemid 29097406)
56. Tamaoka Y., Orikasa H., Sumi Y., Sakakura K., Kamei K., Nagatani M., Ezawa S.: "Direct effect of danazol on endometrial hyperplasia in adenomyotic women: treatment with danazol containing intrauterine device". Hum Cell., 2000, 13, 127.
57. Järvelä I., Tekay A., Santala M., Jouppila P.: "Thermal balloon endometrial ablation therapy induces a rise in uterine blood flow impedance: a randomized prospective color Doppler study". Ultrasound Obstet Gynecol., 2001, 17, 65.
58. Minassian V.A., Mira J.L.: "Balloon thermoablation in a woman with complex endometrial hyperplasia with atypia. A case report". J. Reprod. Med., 2001, 46, 933.
59. Newfield R.S., Spitz I.M., Isacson C., New M.I.: "Long-term mifepristone (RU486) therapy resulting in massive benign endometrial hyperplasia". Clin Endocrinol. (Oxf)., 2001, 54, 399. (Pubitemid 32234206)
60. Tabata T., Yamawaki T., Yabana T., Ida M., Nishimura K., Nose Y.: "Natural history of endometrial hyperplasia. Study of 77 patients". Arch. Gynecol. Obstet., 2001, 265, 85. (Pubitemid 32494271)
61. Tabata T., Yamawaki T., Ida M., Nishimura K., Nose Y., Yabana T.: "Clinical value of dilatation and curettage for abnormal uterine bleeding". Arch. Gynecol. Obstet., 2001, 264, 174. (Pubitemid 32105006)
62. Jacques S.M., Qureshi F., Munkarah A., Lawrence W.D.: "Interinstitutional surgical pathology review in gynecologic oncology: I. Cancer in endometrial curettings and biopsies". Int. J. Gynecol. Pathol., 1998, 17, 36. (Pubitemid 28016700)
63. Gimpelson R.J.: "Not so benign endometrial hyperplasia: endometrial cancer after endometrial ablation". J. Am. Assoc. Gynecol. Laparosc., 1997, 4, 507.
64. Cianferoni L., Giannini A., Franchini M.: "Hysteroscopic resection of endometrial hyperplasia". J. Am. Assoc. Gynecol. Laparosc., 1999, 6, 151.
65. Agorastos T., Vaitsi V., Pantazis K., Efstathiadis E., Vavilis D., Bontis N.: "Aromatase inhibitor anastrozole for treating endometrial hyperplasia in obese postmenopausal women". Eur. J. Obstet. Gynecol. Reprod. Biol., 2005, 118, 239. (Pubitemid 40093842)
66. Agorastos T., Bontis J., Vakiani A., Vavilis D., Constantinidis T.: "Treatment of endometrial hyperplasias with gonadotropin-releasing hormone agonists: pathologic, clinical, morphometric, and DNA-cytometric data". Gynecol. Oncol., 1997, 65, 102. (Pubitemid 27171560)